Login / Signup

Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland.

Amy DymondWill GreenMary EdwardsMaria Angeles Lopez PontGirish Gupta
Published in: PharmacoEconomics - open (2023)
Tirbanibulin is a cost saving intervention for the treatment of AK from the perspective of the Scottish Healthcare System.
Keyphrases
  • randomized controlled trial
  • replacement therapy